Brief: NLS Pharmaceutics AG Agreed To Extend Merger Agreement Termination Date With Kadimastem From Aug 31 To Oct 31
29/08/2025 21:26
Aug 29 (Reuters) - NLS Pharmaceutics AG NLSP.O: NLS PHARMACEUTICS AG: AGREED TO EXTEND MERGER AGREEMENT TERMINATION DATE WITH KADIMASTEM FROM AUG 31 TO OCT 31- SEC FILING Further company coverage: NLSP.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on NewcelX AG
See all newsBrief: Newcelx Announces Pricing Of $1.4 Million Equity Financing At 20% Premium Pricing
Brief: Newcelx Submits Pre-IND Package To FDA For NCEL-101 For Treatment Of Type 1 Diabetes
Brief: Newcelx Updates Corporate Presentation To Highlight Type 1 Diabetes Flagship Program
U.S. STOCKS ON THE MOVE-Eli Lilly, Space stocks, Anixa Biosciences
U.S. STOCKS ON THE MOVE-Intel, Tempus AI, Boeing